Molecular tumor heterogeneity in muscle invasive bladder cancer: Biomarkers, subtypes, and implications for therapy-Reference-Cited by-同舟云学术

Molecular tumor heterogeneity in muscle invasive bladder cancer: Biomarkers, subtypes, and implications for therapy

Published:2018-12 Issue: Volume: Page:
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

da Costa Jose Batista,Gibb Ewan A.,Nykopp Timo K.,Mannas Miles,Wyatt Alexander W.^ORCID,Black Peter C.^ORCID

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference63 articles.

1. Immunotherapy with checkpoint blockade in the treatment of urothelial carcinoma;Siefker-Radtke;J Urol,2018

2. Erdafitinib, a panfibroblast growth factor receptor inhibitor, in patients with metastatic or unresectable urothelial carcinoma and fgfr alterations;Loriot,2018

3. Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial;Petrylak;Lancet,2017

4. Gefitinib or carboplatin–paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2006

5. Genome sequencing identifies a basis for everolimus sensitivity;Iyer;Science,2012

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancer;2024-01-03

2. Identification of hypoxia- and immune- based prognostic signature and validation of TFRC as a potential biomarker and therapeutic target in bladder cancer;2023-12-13

3. Identification of hypoxia- and immune- based prognostic signature and validation of TFRC as a potential biomarker and therapeutic target in BLCA;2023-11-25

4. m5C methylation modification guides the prognostic value and immune landscapes in acute myeloid leukemia;Aging;2023-09-25

5. Epigenetic and Immunological Features of Bladder Cancer;International Journal of Molecular Sciences;2023-06-07